Danaher Corporation $DHR Shares Acquired by Ethic Inc.

Ethic Inc. boosted its position in Danaher Corporation (NYSE:DHR) by 15.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 84,419 shares of the conglomerate’s stock after acquiring an additional 11,490 shares during the period. Ethic Inc.’s holdings in Danaher were worth $18,703,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Danaher during the 2nd quarter worth about $10,492,520,000. Wellington Management Group LLP lifted its position in Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after purchasing an additional 1,542,310 shares during the period. Jupiter Topco LLC bought a new position in shares of Danaher in the 2nd quarter valued at about $1,456,317,000. Generation Investment Management LLP bought a new position in shares of Danaher in the 2nd quarter valued at about $1,287,949,000. Finally, Bank of America Corp DE bought a new position in shares of Danaher in the 2nd quarter valued at about $993,846,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of recent research reports. The Goldman Sachs Group reissued a “buy” rating and set a $275.00 price target on shares of Danaher in a research note on Thursday, October 22nd. Wells Fargo & Company reduced their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Royal Bank Of Canada upped their target price on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Finally, Morgan Stanley upped their target price on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $242.91.

Insiders Place Their Bets

In related news, CAO Christopher Bouda sold 7,598 shares of the business’s stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the transaction, the chief accounting officer owned 9,107 shares in the company, valued at approximately $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 10.80% of the stock is owned by insiders.

Danaher Price Performance

Shares of DHR opened at $230.34 on Friday. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market cap of $162.05 billion, a P/E ratio of 37.70, a price-to-earnings-growth ratio of 2.89 and a beta of 0.76. The stock’s 50-day moving average price is $220.27 and its two-hundred day moving average price is $201.60.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to analyst estimates of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The company’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company earned $1.89 EPS. On average, equities analysts predict that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is presently 26.19%.

Danaher Company Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing.

The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.